Global Prefilled Syringes Market Size, Study by Type (Disposable, Reusable), Material (Glass, Plastic), Application (Anaphylaxis, Diabetes, Others), Distribution Channel, and Regional Forecasts 2022-2032
The global Prefilled Syringes Market is poised to experience USD 6.41 billion exponential growth in 2023, with its valuation projected to reach USD 16.13 billion by 2032, growing at a robust CAGR of 10.8% during the forecast period from 2024 to 2032. Prefilled syringes represent an advanced drug delivery system, catering to growing healthcare demands with precision and user convenience. These devices offer pre-measured medication, thereby minimizing errors, ensuring sterility, and enhancing patient adherence, particularly in chronic disease management and emergency medical interventions.
The market growth is underpinned by the increasing prevalence of chronic diseases, surging demand for self-administration devices, and the growing focus on reducing medication wastage. Technological advancements, particularly in material innovations such as glass and plastic, are augmenting product durability and safety. Additionally, the global shift towards minimally invasive medical procedures further elevates the significance of prefilled syringes. However, high manufacturing costs and stringent regulatory frameworks might pose challenges to market expansion.
North America continues to dominate the market landscape due to its advanced healthcare infrastructure and significant adoption of cutting-edge medical devices. Europe follows closely, supported by a growing geriatric population and favorable reimbursement policies. Meanwhile, the Asia Pacific region emerges as the fastest-growing market, driven by rising healthcare investments, expanding pharmaceutical manufacturing capabilities, and increasing awareness about prefilled syringe benefits.
Prominent players in the industry are actively pursuing strategic collaborations, R&D investments, and product launches to capitalize on market opportunities. For instance, XYZ Corporation recently unveiled a new range of eco-friendly prefilled syringes designed to meet sustainability goals while enhancing performance.
Major market players included in this report are:1. Becton, Dickinson and Company
2. Gerresheimer AG
3. Schott AG
4. West Pharmaceutical Services, Inc.
5. Catalent, Inc.
6. Nipro Corporation
7. Stevanato Group
8. Terumo Corporation
9. Owen Mumford Ltd.
10. Baxter International Inc.
11. Medtronic Plc
12. Pfizer Inc.
13. Novartis AG
14. Johnson & Johnson
15. Sanofi
The detailed segments and sub-segment of the market are explained below:By Type:
• Disposable
• Reusable
By Material:
• Glass
• Plastic
By Application:
• Vaccines and Immunizations
• Anaphylaxis
• Rheumatoid Arthritis
• Diabetes
• Autoimmune Diseases
• Oncology
• Others
By Distribution Channel:
• Hospitals
• Mail Order Pharmacies
• Ambulatory Surgery Centers
By Region:
North America:
• U.S.
• Canada
Europe:
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific:
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific
Latin America:
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa:
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa
Years considered for the study are as follows:• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032
Key Takeaways• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.